Member Info for Wigwammer

It was a positive RNS donovan, and those investors who have been accumulating shares over the last 12 months will be pleased with the price performance. Two late stage assets in blockbuster indications, a new trial involving a much higher dosage of p140, fda and cnrs involvement and trial approval, a developing IP estate, low cash burn, very low valuation. High risk but very high reward and invest an appropriate amount. Fingers crossed for 2025.

But I didn’t recommend accumulating then, nolupus. You just made it up. But even if I had, I would have more respect for someone who can at least make a decision, rather than someone who never makes one at all. You, lollywally, 3 post pete - just post event commentators. ATB

Go away, silly man. And FGS come up with a decision at some point.

For the record, I have spent a material amount of time recommending that people accumulate imm stock over the last 12 months, and anyone who did so would now be sitting on a material capital gain that they can either lock in, or allow to run. It’s all here as a matter of record. By contrast, anyone who acted on the nolupus commentary would have nothing to show for it but utter confusion.

I have a view which I am happy to share with others, nolupus. I have no interest in your view because you never appear to have one. You don’t commit to any decision, just endless post event commentary.

Nolupus - I couldn’t care less what you appreciate. I have yet to see you commit to a decision on the shares at any point. Perhaps you can’t. Just a lot of post event commentary. Atb

Lollywally currently 50% down on his position here. 3 post pete has never had a position here. Let’s bear this in mind as we contemplate the value of their posts :)

Bye then :)

Ah 3 post Pete is flash212. The guy who was posting negative stuff here when the shares were around 1p last March. Touch of an ape :)

To repeat - one of the most interesting things about immupharma is that their cash burn is incredibly low. Around £1.3m pa. If you don’t use a lot of cash, then you don’t need a lot of cash. GLA

Poor old 3 post pete. He had all his best arrows lined up this morning. He bought a glistening new bow after bristling about IMM all weekend. This morning he let the arrows fly - zzzzzzooooom - and result : none of them hit and the shares rose… Now he’s all just wordy and clutching at straws. The market just isn’t interested mate :)

Masterblast had a IMM price target of around 20p! Come on fella, you’re too emotionally tied up to be objective here.

Had a quick look lifeofpi, and it appears masterblast owned IMM shares back in June 2023 and was very bullish on them here. Unfortunately, his timing was not good and he will have lost a fair bit when he sold. Hope he is having better luck elsewhere though. ATB

Old 3 post pete flying off a few more arrows. Must be bitterly disappointed with the reaction so far :)

Rampers too eh?! There are some good posts on this board explaining why the shares may be undervalued IMO. Sorry if you don’t agree and best of luck with your investments.

“Hype”.. “desperados”.. “delusional”.. sounds more like a rather emotive condemnation of us holders. Not sure why you’re so emotional about it and best wishes with your investments.

Oh dear. Not falling as 3 post pete predicted. The spite is strangely familiar - like a certain nob over on advfn :)

One of the things that makes immupharma so interesting is the incredibly low cash burn - around £1.3m pa. If you don’t use a lot of cash then you don’t need a lot of cash. IMM has multiple avenues for raising that sort of money - a modest upfront payment, warrants, or a small dilution. ATB

3 post Peter has sold the imaginary shares that he never reported buying. Another green eyed hindsight trader

Far more proof lupuzor works than that you bought at 2p on Thursday, peterpharma (who only joined lse yesterday).